2019
DOI: 10.1101/711424
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Regulation of neuronal mRNA splicing and Tau isoform ratio by ATXN3 through deubiquitylation of splicing factors

Abstract: 33The ubiquitylation/deubiquitylation balance in cells is maintained by 34Deubiquitylating enzymes, including ATXN3. The precise role of this protein, 35 mutated in SCA3, remains elusive, as few substrates for its deubiquitylating 36 activity were identified. Therefore, we characterized the ubiquitome of 37 neuronal cells lacking ATXN3, and found altered polyubiquitylation in a large 38 proportion of proteins involved in RNA metabolism, including splicing factors. 39Using transcriptomic analysis and reporter m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 83 publications
0
4
0
Order By: Relevance
“…In later stages, these phenomena would be sequentially overridden by axonal loss (mirrored by a progressive rise in NfL) and neuronal cell loss. Finally, there could be a progressive dysregulation of tau expression in the SCA3 disease course, as shown in a preliminary study [19]. Nonetheless, for its implementation as a biomarker in SCA3, further studies in tau kinetics in CSF and blood will be required, as well as longitudinal clinical studies in large patient cohorts.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In later stages, these phenomena would be sequentially overridden by axonal loss (mirrored by a progressive rise in NfL) and neuronal cell loss. Finally, there could be a progressive dysregulation of tau expression in the SCA3 disease course, as shown in a preliminary study [19]. Nonetheless, for its implementation as a biomarker in SCA3, further studies in tau kinetics in CSF and blood will be required, as well as longitudinal clinical studies in large patient cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…In a pilot study, cerebrospinal fluid (CSF) tau was elevated in patients with spinocerebellar ataxia type 2 (SCA2) and multiple system atrophy, cerebellar type (MSA‐c), compared to controls [18]. In SCA3, dysregulation of MAPT splicing with a decreased 4R/3R ratio has been observed [19].…”
Section: Introductionmentioning
confidence: 99%
“…Proteins SFSWAP, SRSF7, and DDX17 are involved in the formation of mature mRNAs through the control of mRNA transcription and splicing. In particular, SFSWAP and SRSF7 alter the spliceosome by repressing the splicing of exon 10 of the Tau protein [60,61]. Tau has been implicated in the pathogenesis of neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease [62].…”
Section: Mrna Transcription and Splicing Regulation Of Differentiatio...mentioning
confidence: 99%
“…The alternative splicing of Tau exon 10 causes a dysregulation in the balance of Tau isoforms, which has been shown to be correlated with the development of these neurodegenerative diseases [63]. SRSF7, serine/argininerich splicing factor 7, also has been associated with the ubiquitin proteasome pathway through which the Tau protein balance may be affected [61]. However, SFSWAP (splicing factor, suppressor of the white-apricot homolog), which is also known in humans as SRSF8, was identified through homology to other SRSF proteins, so the mechanism is less well understood than SRSF7 [64].…”
Section: Mrna Transcription and Splicing Regulation Of Differentiatio...mentioning
confidence: 99%